PUBLISHER: DataM Intelligence | PRODUCT CODE: 1542872
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1542872
Overview
Global Breast Surgery Retractors Market reached US$ 319.40 million in 2023 and is expected to reach US$ 566.45 million by 2031, growing at a CAGR of 7.6% during the forecast period 2024-2031.
Breast surgery retractors are used to hold an incision or wound open while a surgeon works. The retractor can also be used to hold tissues or organs out of the way during surgery. Hand retractors are retractors that must be held by an assistant, a robot, or the surgeon during a procedure. The breast surgical retractor lighting will allow surgeons to better navigate in deep or minimally-open cavities.
These instruments can be used for various techniques, such as the latissimus dorsi flap, as well as for different accesses via the axilla or the inframammary fold. These are available for plastic, aesthetic, and reconstructive surgeries. The major features associated with breast surgery retractors are they can be used with an endoscope and for breast augmentation using the inframammary or trans-axillary approach.
Market Dynamics: Drivers & Restraints
Increasing prevalence of breast cancer
The increasing prevalence of breast cancer among women is the predominant driving factor of the global market for breast surgery retractor market. The number of surgical procedures necessary for diagnosis, treatment, and reconstruction rises in parallel to the incidence of breast cancer. This rapidly impacts the demand for various types of breast surgery retractors, which are utilized to facilitate these procedures.
For instance, according to the World Cancer Research Fund International, it is stated that there were 2,296,840 new cases of breast cancer in 2022 among women.
Every country contains a large number of breast cancer patients which increases the demand for breast surgery retractors. For instance, China accounts for over 357,161 individuals suffering from breast cancer and the U.S. accounts for almost 274, 375 individuals with breast cancer. Thus, the increasing number of individuals with breast cancer could raise the market growth.
Regulatory hurdles
The regulatory approval process for medical devices, including breast surgery retractors, can be extensive. This often involves lengthy testing, clinical trials, and documentation, which can cause delays in the launch of the new product. Long approval processes can lead to delays in the introduction of novel retractors to the market, limiting the capacity of companies to capitalize on emerging trends or solve immediate market demands.
Market Segment Analysis
The global breast surgery retractors market is segmented based on product type, usage type, application, end-users and region.
Double-handle retractor segment is expected to dominate the market share
Double-handle retractors are frequently utilized in breast surgery because they allow greater precision and wider exposure to the surgical area. They are especially beneficial in treatments that require long-term stability in retraction. The dual-handle design allows more accurate and adaptable retraction, which is critical for fulfilling various surgical needs and retaining an ideal position of retracted tissue.
Double-handle retractors offer additional flexibility in terms of the angles and positions they can maintain. This adaptability is useful for difficult treatments requiring significant tissue retraction and manipulation. These features allow the higher adoption rates by the surgeons and the healthcare providers holding them in the dominant position in the market share.
Market Geographical Share
North America is expected to hold a significant position in the breast surgery retractors market share
North America dominates the global breast surgery retractors market during the forecast period owing to the rise in awareness among the diseased population (breast cancer) regarding the availability of surgical methods across the region and wide acceptance of cosmetic procedures.
The rapid surge in breast augmentation and reconstruction procedures performed across the region as these surgery retractors are majorly used in performing these procedures is additionally driving the global breast surgery retractors market during the forecast period.
According to the report by the Toronto Plastic Surgeons in 2022, it is stated that in the United States alone, 255,200 breast augmentation surgeries were performed in 2022, making it the leader in this category globally with approximately 11.7% of the total number of breast augmentations performed worldwide. Thus, the above factors are expected to drive the market growth in the region.
Single-handle Retractor
Double-handle Retractor
Disposable
Reusable
Mastectomy
Lumpectomy
Plastic Surgery
Breast Reconstruction
Others
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
North America
The U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the market include Accurate Surgical & Scientific Instruments, Integral Lifesciences Corporation, Thompson Surgical, Medtronic Plc, Cooper Surgical Inc., Black & Black Surgical, Novo Surgical Inc., Hayden Medical Inc., Accurate Surgical & Scientific Instruments and Marina Medical Inc. among others.
To visualize the global breast surgery retractors market segmentation based on product type, usage type, application, end-users, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of breast surgery retractors market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.
The global breast surgery retractors market report would provide approximately 53 tables, 47 figures, and 176 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies